Evidence map›Paper›PMID 40298087›Full record

ArticleeLife2025

LC8 enhances 53BP1 foci through heterogeneous bridging of 53BP1 oligomers.

Jesse Howe, Douglas Walker, Kyle Tengler, Maya Sonpatki, Patrick N Reardon, Justin W C Leung, Elisar J Barbar

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jesse HoweDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, United States.
Douglas WalkerDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, United States.
Kyle TenglerDepartment of Radiation Oncology, University of Texas Health and Science Center, San Antonio, United States.
Maya SonpatkiDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, United States.
Patrick N ReardonOregon State University NMR Facility, Oregon State University, Corvallis, United States.
Justin W C LeungDepartment of Radiation Oncology, University of Texas Health and Science Center, San Antonio, United States.ORCID https://orcid.org/0000-0003-4601-390X
Elisar J BarbarDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, United States.ORCID https://orcid.org/0000-0003-4892-5259

Funding

Deciphering the chromatin-based DNA damage response pathwayR35GM137798 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Justin Wai Chung Leung · 2020 to 2026
$2.4M
Multiscale characterization of a unique class of duplex, multivalent IDP systems-- Administrative Supplement to Support Undergraduate Summer Research ExperiencesR01GM141733 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BARBAR, ELISAR J, ZUCKERMAN, DANIEL M · 2021 to 2024
$1.9M
Mechanistic characterization of the cell cycle-dependent DNA repair pathway- ResubmissionR01CA244261 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI Justin Wai Chung Leung · 2021 to 2026
$1.5M
Acquisition of a 700 MHz NMR SpectrometerS10OD018518 · OD · OREGON STATE UNIVERSITY · PI BARBAR, ELISAR J · 2015 to 2015
$1.3M
American Cancer Society 10.53354/acs.rsg-20-131-01-dmc.pc.gr.142479American Cancer Society 10.53354/pc.gr.151537American Cancer Society RSG-20-131-01-DMCARCS Oregon Chapter Graduate Student FellowshipMJ Murdock Charitable Trust #2014162National Institute of Health 1S10OD018518NCI NIH HHS R01 CA244261NCI NIH HHS R01CA244261NIGMS NIH HHS R01 GM141733NIGMS NIH HHS R01GM141733NIGMS NIH HHS R35 GM137798NIGMS NIH HHS R35GM137798NIH HHS 1S10OD018518NIH HHS S10 OD018518University of Texas Health Science Center at San Antonio STARs award
6 · The paper itself

Abstract

53BP1 is a key player in DNA repair and together with BRCA1 regulate selection of DNA double-strand break repair mechanisms. Localization of DNA repair factors to sites of DNA damage by 53BP1 is controlled by its oligomerization domain (OD) and binding to LC8, a hub protein that functions to dimerize >100 clients. Here, we show that 53BP1 OD is a trimer, an unusual finding for LC8 clients which are all dimers or tetramers. As a trimer, 53BP1 forms a heterogeneous mixture of complexes when bound to dimeric LC8, with the largest mass corresponding to a dimer-of-trimers bridged by 3 LC8 dimers. Analytical ultracentrifugation and isothermal titration calorimetry demonstrate that only the second of the three LC8 recognition motifs is necessary for a stable bridged complex. The stability of the bridged complex is tuned by multivalency, binding specificity of the second LC8 site, and the length of the linker separating the LC8 binding domain and OD. 53BP1 mutants deficient in bridged species fail to impact 53BP1 focus formation in human cell culture studies, suggesting that the primary role of LC8 is to bridge 53BP1 trimers, which in turn promotes recruitment of 53BP1 at sites of DNA damage. We propose that the formation of higher-order oligomers of 53BP1 explains how LC8 elicits an improvement in 53BP1 foci and affects the structure and functions of 53BP1.

Indexed as

Protein MultimerizationTumor Suppressor p53-Binding Protein 1DNA DamageDNA RepairHumansProtein BindingTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 153BP1heterogeneityhumanisothermal titration calorimetryLC8molecular biophysicsmultivalencyoligomerizationstructural biology

Identifiers

PMID40298087
PMCPMC12187134

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.